CEO | Phoenix Copper
OMC Chambers, Wickhams Cay 1, ROAD TOWN, VG1110 Virgin Islands (British) (GB)
April 29th, 2022
Phoenix Copper could go into production as early as 2023 and surprise the market with its production costs and other general conditions. In an interview, CEO Ryan McDermott explains why the Company doesn't believe in making a lot of promises, why the planned Empire Open Pit project doesn't anticipate any environmental impacts, and what other potential lies dormant in the Company.
CEO | NervGen Pharma
2955 Virtual Way, Suite 480, V5M 4X6 Vancouver, BC (CAN)
Interview NervGen Pharma: "We have a drug with the potential to treat Alzheimer's, MS, spinal cord injury and stroke".
April 14th, 2022
Multiple sclerosis, Alzheimer's disease or even strokes have something in common with spinal cord injury: they damage the nervous system. This makes them all incredibly difficult to treat. But a therapeutic breakthrough finally seems possible. In the 1990s, Dr. Jerry Silver discovered the root cause for why debilitating damage to the central nervous system cannot be repaired. What was a revolutionary discovery at the time is now accepted science. The NervGen team, which has exclusively licensed the technology that came from Dr. Silver’s lab, is now at an exciting time in the development of a potentially paradigm changing milestone, based on his 30 years of important work. The breakthrough could come as early as next year. We talk about NervGen's approach and plans for a Nasdaq listing with NervGen Executive Chairman Bill Radvak.
General Manager and Executive Director | Hong Lai Huat
10 Bukit Batok Crescent, #13-05, The Spire, S658079 Singapore (SG)
+65 6861 0330
April 6th, 2022
Cambodia offers breathtaking beaches, the world wonder of the Angkor Wat temples and an emerging economy: the rating agency Fitch expects growth of 4.7% in 2022. In this interview, Dylan Ong, General Manager and Executive Director of Hong Lai Huat, explains the opportunities offered by Cambodia's real estate market, why the Group has an edge over other investors, and which joint venture could generate big fantasy as early as 2022.
CEO | Cardiol Therapeutics
602-2265 Upper Middle Road East, L6H 0G5 Oakville (CAN)
+1 (289) 910-0850
March 10th, 2022
In this interview, Cardiol Therapeutics’ President and CEO David Elsley explains the unique selling points of the Company’s lead product, CardiolRx™, an oral cannabidiol formulation pharmaceutically manufactured under cGMP. He explains why the upcoming clinical trials could result in exclusive multi-year distribution agreements, why the financing last November was a good decision, and how major funds from the U.S. currently stand by Cardiol Therapeutics.
CEO | Power Nickel
82 Richmond St East Suite 202, M5C 1P1 Toronto (CAN)
+1 416 900-5445
March 8th, 2022
A promising nickel project in Quebec, several gold properties in Canada and Chile, and a license agreement with Teck Resources that could yet provide surprises - Power Nickel's list of activities is long. But the Company is consolidating. As early as the second quarter, historical data is expected to be converted into an updated resource estimate for the flagship NISK project. Shareholders also stand to receive bonus shares later this year. Here is what Terry Lynch, CEO of Power Nickel, has in mind for 2022 and what the Company needs to do to be valued at CAD 800 million instead of CAD 15 million.
Dr. Moutih Rafei
Director and VP of research and development | Defence Therapeutics
1680 – 200 Burrard Street, V6C 3L6 Vancouver (CAN)
+1 (514) 947 2272
Defence Therapeutics Interview: 'Accum™ is the most sought-after multi-tool in the pharmaceutical industry.'
February 23rd, 2022
The case of the German biotech CureVac has shown that costly projects often fail because of the finer details. Canadian biotech Defence Therapeutics has developed a drug enhancer with its patented Accum™ technology, which works with many technologies and, even on its own, has a highly toxic effect on cancer cells. Dr. Moutih Rafei, director and VP of research and development at Defence Therapeutics, explains in an interview how Defence Therapeutics is working toward upcoming Phase I trials around vaccines for breast and skin cancer, how else the versatile technology can be used, and to which pharma giants it has specific scientific tie-ins.
Director | Altech Advanced Materials AG
Ziegelhäuser Landstraße 3, 69120 Heidelberg (DE)
January 27th, 2022
Uwe Ahrens, director of Altech Advanced Materials, is convinced that e-cars will soon be cheaper than combustion engines. Ahrens and his team are pushing ahead with innovations and are not afraid of a price war in the battery industry. The reason: with its technology, the Company sees the potential to make batteries for e-cars significantly more powerful. Find out how this works and what other aces Altech Advanced Materials has up its sleeve in an interview with the experienced industry manager.
President and CEO | Barsele Minerals
Suite 1130 - 1055 W. Hastings Street, V6E 2E9 Vancouver (CAN)
December 15th, 2021
Barsele Minerals operates its promising Swedish Barsele project in a joint venture with commodity giant Agnico Eagle. The project scores with high grades and the potential for up to 4 million ounces of gold. Sweden is attractive due to low energy prices and secure framework conditions. But Agnico Eagle sees its future more in North America. The necessary exploration budget to make the breakthrough at Barsele has so far failed to materialize. Now new options are opening up. In an interview, Barsele CEO Gary Cope explains the background and draws parallels to a billion-dollar company.
CEO | CoinSmart Financial Inc.
1075 Bay Street, Unit 403, M5B 2B2 Toronto (CAN)
December 8th, 2021
While many companies around blockchain and cryptocurrencies go on the hunt for completely unregulated customers, the Canadian crypto platform CoinSmart has relied on exchanges with authorities from the very beginning. Today, CoinSmart is active in 40 countries worldwide and regulated not only in Canada but also in the USA and the EU. In an interview, CoinSmart CEO Justin Hartzman explains why this approach will bring long-term benefits, how CoinSmart plans to bring traditional financial products onto the blockchain, and why the share price could soon increase fivefold.
CEO | Almonty Industries
100 King Street West, M5X 1C7 Toronto (CAN)
+1 (647) 438-9766
November 25th, 2021
Charge faster, drive longer. Thanks to the growing use of tungsten in batteries, something that sounds like a "make a wish" for e-car drivers is becoming a reality. Almonty CEO Lewis Black explains in an interview what other role tungsten can play, how things stand with the Sangdong gigafactory project in South Korea, why the Company could not ask for a better location, and why the share is undervalued.
President | Prospect Ridge Resources
1288 West Cordova Street Suite 2807, V6C 3R3 Vancouver (CAN)
November 24th, 2021
Although the first drilling program is not scheduled to start until next spring, Prospect Ridge Resources and its Holy Grail project are already the center of attention. The reason: mining veteran Michael Iverson unceremoniously interrupted his retirement after seeing the analyses of initial rock samples. In this interview with Nick Luksha, President of Prospect Ridge Resources, we find out why the project can make good news even in winter, why the team plans to drill up to 20,000m in 2022, and why the movers and shakers behind Prospect Ridge Resources are taking their cue from successful pizza makers.
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)
October 13th, 2021
While established manufacturers of cars and buses are announcing less ambitious targets for hydrogen by 2030, Clean Logistics is already getting serious: Thanks to modular processes, trucks and buses will soon be given a new lease of life on a large scale - CO2-neutral, of course. Clean Logistics CEO Dirk Graszt explains in an interview how this will work, who is behind the Company, and why the demand from potential customers is already high.